Neonatal Med.  2016 Feb;23(1):59-63. 10.5385/nm.2016.23.1.59.

Oral Proton Pump Inhibitor for Treatment of Congenital Chloride Diarrhea

Affiliations
  • 1Department of Pediatrics, Ajou University Hospital, Ajou University School of Medicine, Suwon, Korea. neopedlee@gmail.com
  • 2Department of Medical Genetics, Ajou University Hospital, Ajou University School of Medicine, Suwon, Korea.
  • 3Department of Pediatrics, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, Korea.

Abstract

Congenital chloride diarrhea (CCD) is a rare autosomal recessive disease, which is characterized by electrolyte absorption defect due to impaired function of the Cl-/HCO3 - exchanger in the ileum and the colon. Its main features are profuse watery diarrhea, high fecal chloride concentration, and failure to thrive. Profuse watery diarrhea characterized by a high concentration of chloride in stools results in hypochloremia, hyponatremia, and dehydration with metabolic alkalosis. Early detection and therapeutic intervention can prevent life-threatening symptoms of CCD and growth failure. Recently, several therapies, such as proton pump inhibitors and butyrate, have been suggested for amelioration of diarrhea. Here, we report a case of CCD in a preterm male infant who was successfully treated with an oral proton pump inhibitor.

Keyword

Congenital chloride diarrhea; Alkalosis; SLC26A3; Proton pump inhibitor; Omeprazole

MeSH Terms

Absorption
Alkalosis
Butyrates
Colon
Dehydration
Diarrhea*
Failure to Thrive
Humans
Hyponatremia
Ileum
Infant
Male
Omeprazole
Proton Pump Inhibitors
Proton Pumps*
Protons*
Butyrates
Omeprazole
Proton Pump Inhibitors
Proton Pumps
Protons
Full Text Links
  • NM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr